Results
1 -
10 of
15
(Click
here to explore results)
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 4 Catechol‐O‐Methyl‐Transferase Inhibitors: Present Problems and Relevance of the New Ones . P. Nuno Palma, László E. Kiss, Patrício Soares‐da‐Silva
, 2013
, Pages 83-109
Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 5 Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development . Ramón Cacabelos, Juan Carlos Carril, Oscar Teijido
, 2017
, Pages 75-141
Biotransformations: A Survey of the Biotransformations of Drugs and Chemicals in Animals, Substituted aromatic compounds . D. R. Hawkins
, 1996
, Volume 7
, Pages 95-192
Emerging Drugs and Targets for Parkinson's Disease, Subject Index
, 2013
, Pages 390-402
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 5 Pharmacologic Management of Dopaminergic‐Induced Dyskinesias in Parkinson’s Disease . Mildred D. Gottwald, Michael J. Aminoff
, 2013
, Pages 110-125
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 13 5‐HT1A Receptors as a Therapeutic Target for Parkinson’s Disease . Saki Shimizu, Yukihiro Ohno
, 2013
, Pages 308-326
New Applications of NMR in Drug Discovery and Development, CHAPTER 3 High‐Resolution NMR‐Based Metabolic Profiling in Drug Discovery and Development . Nigel J. Waters
, 2013
, Pages 101-133
Drug Discovery for Psychiatric Disorders, CHAPTER 6 Treating the Cognitive Deficits of Schizophrenia . Bruce N. Rogers, David L. Gray
, 2012
, Pages 123-156
Glossary of Terms Used in Molecular Toxicology, Terms Beginning with C
, 2020
, Pages 57-96
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 6 Influence of Aromatic Rings on ADME Properties of Drugs . Deepak Dalvie, Sajiv Nair, Ping Kang, Cho-Ming Loi
, 2010
, Pages 275-327